首页> 外文学位 >Calcitonin gene-related peptide and its novel receptors in hypoxic pulmonary hypertension.
【24h】

Calcitonin gene-related peptide and its novel receptors in hypoxic pulmonary hypertension.

机译:降钙素基因相关肽及其在低氧性肺动脉高压中的新受体。

获取原文
获取原文并翻译 | 示例

摘要

The primary goal of this research was to examine the vasodilatory action of calcitonin gene-related peptide (CGRP) in the pulmonary circulation in hopes to enhance the efficacy of this endogenous lung peptide during pulmonary hypertensive states.; The first aim was to investigate the protective efficacy in rats of selected N-terminal CGRP fragments in hypoxic pulmonary hypertension (HPH). This strategy has the potential of avoiding the competitive inhibitory effects of C-terminal CGRP metabolites. When chronically infused via the right jugular vein during 14 days of hypobaric hypoxia, CGRP1–8, 1–13 and 1–14 significantly diminished the hypoxia-induced elevation of pulmonary artery pressure (PPA), pulmonary arterial medial thickness, and right ventricular hypertrophy, suggesting that these CGRP sequences can mitigate chronic HPH in rats.; The second aim was to examine pulmonary existence of the novel putative CGRP receptors RDC-1 and calcitonin receptor-like receptor (CRLR), and also receptor activity modifying proteins (RAMPs) 1, 2, and 3. RAMP1 and RAMP2 are required for CRLR's function as CGRP and adrenomedullin receptors, respectively, whereas the function of RAMP3 is unclear. Changes in their specific mRNA levels upon airway hypoxia were also determined. This was accomplished by using qualitative, semiquantitative, and real-time RT-PCR. Our results show upregulation of RDC-1 and RAMPs 1 and 3 in hypoxic rat lung, whereas there was no change in CRLR and RAMP2 mRNAs.; The third aim was to investigate the roles of RDC-1 and RAMP1 in mediating pulmonary vasodilation by selectively inhibiting their synthesis using in vivo antisense oligonucleotide (AS) -mediated gene knock-down. CGRP AS was used as a technical control. CGRP, RAMP1 and RDC-1 AS significantly exacerbated HPH in 1-week hypobaric hypoxic rats compared to hypoxic mismatched-AS (MM) and saline vehicle controls. CGRP- and RAMP1 AS also raised PPA in normoxic rats acutely exposed to 10% O2 to levels above MM and saline controls, and normoxic CGRP AS-treated rats had higher basal vascular tone. These data confirm the protective role of CGRP in the pulmonary circulation, and suggest that endogenous RAMP1 and RDC-1 are essential in modulating PPA during hypoxia.
机译:这项研究的主要目的是研究降钙素基因相关肽(CGRP)在肺循环中的血管舒张作用,以期在肺动脉高压状态下增强这种内源性肺肽的功效。第一个目的是研究所选的N端CGRP片段在大鼠低氧性肺动脉高压(HPH)中的保护作用。该策略具有避免C末端CGRP代谢产物竞争性抑制作用的潜力。在低压缺氧的14天中通过右颈静脉长期输注时,CGRP 1–8、1–13 1–14 显着减轻了低氧引起的肺部抬高动脉压(PPA),肺动脉中层厚度和右心室肥大,表明这些CGRP序列可以减轻大鼠的慢性HPH。第二个目的是检查新型推定的CGRP受体RDC-1和降钙素受体样受体(CRLR)在肺中的存在,以及受体活性修饰蛋白(RAMP)1、2和3。CRLR需要RAMP1和RAMP2。作用分别作为CGRP和肾上腺髓质素受体,而RAMP3的功能尚不清楚。还确定了气道缺氧后其特定mRNA水平的变化。这是通过使用定性,半定量和实时RT-PCR完成的。我们的结果显示低氧大鼠肺中RDC-1和RAMPs 1和3的上调,而CRLR和RAMP2 mRNA没有变化。第三个目的是研究RDC-1和RAMP1在体内通过体内反义寡核苷酸(AS)介导的基因敲除选择性抑制其合成,从而在介导肺血管舒张中发挥作用。 CGRP AS被用作技术控制。 CGRP,RAMP1和RDC-1 AS与低氧错配的AS(MM)和生理盐水对照组相比,在1周的低氧缺氧大鼠中可显着加重HPH。 CGRP和RAMP1 AS也使正常暴露于10%O 2 的常氧大鼠的PPA升高至高于MM和生理盐水的水平,而常氧CGRP AS治疗的大鼠具有更高的基础血管张力。这些数据证实了CGRP在肺循环中的保护作用,并暗示内源性RAMP1和RDC-1在缺氧期间调节P PA 是必不可少的。

著录项

  • 作者

    Qing, Xin.;

  • 作者单位

    The University of Wisconsin - Madison.;

  • 授予单位 The University of Wisconsin - Madison.;
  • 学科 Biology Veterinary Science.; Biology Animal Physiology.
  • 学位 Ph.D.
  • 年度 2002
  • 页码 172 p.
  • 总页数 172
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 动物学;生理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号